HE homepage

Mental Health Illness

Companion bills in the state legislature would bar artificial intelligence apps from providing services of human professionals in schools.

Medicare Advantage Part C clipboard payment

Aetna is the latest to sue, pointing to re-used metrics that were discarded in a court victory by Clover Health. CMS is appealing that decision.

insurance

The data comes from the Commonwealth Fund. The group’s annual survey found that uninsured rates among all working-aged adults in the U.S. are rising, now standing at 11%—a number expected to go up as Medicaid work requirements go into effect.

Many details, including the number of victims and the method hackers used to perform the data breach, are unknown. The company said the incident is still being investigated with the help of law enforcement. 

Aubrey Shick, a digital health policy expert on regulatory and product strategy with Launch and Logic LLC, and a former Senior Digital Health Advisor at the U.S. Food and Drug Administration (FDA), explains how the Trump administration's push for faster artificial intelligence (AI) adoption in healthcare is being done and challenges for the FDA amid government downsizing.

Expertise and commitment of FDA reviewers remain in place, but the agency’s ability to communicate openly with industry has become a significant concern.

Andrew Einstein, MD, PhD, FACC, MASNC, MSCCT, FSCMR, incoming 2027 president of the American Society of Nuclear Cardiology (ASNC), professor of medicine in radiology, and director of nuclear cardiology, cardiac CT and cardiac MRI at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, discusses the potential and limitations of using coronary CT angiography (CCTA) as a screening modality. He also discusses the role of opportunistic imaging.

Andrew Einstein, MD, PhD, spoke to Cardiovascular Business about the potential benefits and limitations of using coronary CT angiography as a screening modality.